Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 26

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 26
---
,735 
  
    Other Segments items 
     388,639  
     288,116  
     9,414  
     686,169 
  
    Total operating expenses 
     4,890,879  
     3,333,255  
     1,414,062  
     9,638,196 
  
     Operating income (loss) 
    $(4,890,879) 
    $1,526,020  
    $(1,349,811) 
    $(4,714,670)

    September 30, 2025 

    Dental  
    Medical  
    Corporate  
    Total 
  
    Total Assets 
    $6,504,045  
    $376,246  
    $1,605,732  
    $8,486,023 

     6,504,045  
     376,246  
     1,605,732  
     8,486,023 

    December 31, 2024 

    Dental  
    Medical  
    Corporate  
    Total 
  
    Total Assets 
    $5,359,734  
    $444,513  
    $3,992,825  
    $9,797,072 

     5,359,734  
     444,513  
     3,992,825  
     9,797,072 

NOTE
11– CONCENTRATIONS

Milestone
Scientific has informal arrangements with third-party U.S. manufacturers of the STA devices, and epidural instruments pursuant to which
they manufacture these products under specific purchase orders which contains advance payments for long lead items for production.
Advances on contracts have been classified as current at September 30, 2025 and December 31, 2024. The termination of the manufacturing
relationship with any of these manufacturers could have a material adverse effect on Milestone Scientific’s ability to produce
and sell its products. Although alternate sources of supply exist, and new manufacturing relationships could be established, Milestone
Scientific would need to recover its existing tools or have new tools produced. Establishing new manufacturing relationships could involve
significant expense and delay. Any curtailment or interruption of the supply, because of termination of such a relationship, would have
a material adverse effect on Milestone Scientific’s financial